MicroRNAs and atrial fibrillation: new fundamentals

Zhiguo Wang1, Yanjie Lu, Baofeng Yang

  • 1Research Center, Montreal Heart Institute, 5000 Belanger East, Montreal, Canada PQ H1T 1C8. wz.email@gmail.com

Cardiovascular Research
|November 6, 2010
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of gene expression implicated in atrial fibrillation (AF). This review explores current research on miRNA roles in AF development and maintenance, offering future research directions.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia with significant health and economic impacts.
  • AF pathogenesis involves altered gene expression crucial for atrial function.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are increasingly recognized in cardiovascular disease.

Purpose of the Study:

  • To review the current understanding of microRNA (miRNA) involvement in atrial fibrillation (AF).
  • To discuss the molecular mechanisms linking miRNAs to cardiac excitability and AF.
  • To present recent research findings and future perspectives on miRNAs in AF.

Main Methods:

  • Literature review of studies investigating miRNA roles in AF.
  • Analysis of experimental data on miRNA expression and function in AF models.
  • Synthesis of current knowledge on miRNA biology and AF mechanisms.

Main Results:

  • Emerging evidence highlights miRNAs as critical regulators in AF.
  • Specific miRNAs are implicated in the initiation and maintenance of AF.
  • miRNA research offers insights into the molecular underpinnings of AF.

Conclusions:

  • MicroRNAs represent a significant area of research for understanding and potentially treating AF.
  • Further investigation into miRNA-mediated gene regulation is crucial for advancing AF therapies.
  • Future research should focus on the therapeutic potential of targeting miRNAs in AF.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Dysrhythmias I: Introduction01:15

Dysrhythmias I: Introduction

Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...